# Hydroxyzine Pamoate

NDC: 76420-920
Generic name: Hydroxyzine Pamoate
Labeler / Manufacturer: Asclemed USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 19840701

FDA application: ANDA088496

## Active ingredients

- HYDROXYZINE PAMOATE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"76420-920"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=76420-920
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=82187031-779e-47bc-943c-eb1a1ef30a7a